MyAverix Finance
US · Healthcare
Rapport Therapeutics, Inc. Common Stock (RAPP)
Biotechnology
Rapport Therapeutics, Inc. Common Stock (RAPP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RAPP
Rapport Therapeutics, Inc. Common Stock (RAPP) — FAQ
What is RAPP's P/E ratio?
The price-to-earnings (P/E) ratio for Rapport Therapeutics, Inc. Common Stock (RAPP) is 25.00 (data as of 2026-05-23).
Does Rapport Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Rapport Therapeutics, Inc. Common Stock (RAPP). Check the MyAverix Finance app for the latest dividend data.
What sector is Rapport Therapeutics, Inc. Common Stock in?
Rapport Therapeutics, Inc. Common Stock (RAPP) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RAPP listed on?
RAPP is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.